june/?92o^^^'"°'-}      A^^^^-^  Items  and  Personal  Notes.  431 
Prof.  Remington,  and  especially  that  relating  to  the  pharmacopoeial 
revision  was  invaluable  to  him  as  it  had  given  him  an  acquaintance 
with  the  methods  of  revision  and  with  the  personal  characteristics 
of  many  of  the  men  who  were  engaged  in  pharmacopoeial  and  re- 
search work.  He  appreciated  greatly  the  promised  cooperation  and 
unanimity  of  spirit  that  appeared  to  be  pervading  the  entire  Com- 
mittee that  had  been  selected  for  the  tenth  revision. 
The  du  Fonts  to  Manufacture  Synthetic  Camphor. — 
Mr.  R.  M.  Carpenter,  Vice-President  of  the  B.  I.  du  Pont  de  Ne- 
mours Company,  has  recently  announced  that  his  company  has 
made  such  progress  in  the  manufacture  of  synthetic  camphor  that 
they  are  "practically  out  of  the  woods,"  and  that  this  will  be  of  great 
advantage  to  all  manufacturers  of  celluloid  or  similar  products. 
This  will  relieve  the  demand  for  natural  camphor  for  industrial 
purposes  and  make  it  more  completely  available  for  medicinal  use 
and  should  result  in  a  material  reduction  in  the  price  of  the  native 
product . 
The  Monsanto  Chemicai,  Works  Estabi^ishes  an  Engush 
Branch. — ^The  Monsanto  Chemical  Works  of  St.  Louis,  Mo.,  has 
announced  that  they  have  amalgamated  in  Great  Britain  with  the 
old  established  firm  of  R.  Graesser,  Ltd.,  of  Ruabon,  N.  Wales, 
who  were  leading  manufacturers  of  phenol  and  coal  tar  derivatives. 
The  amalgamated  firm  will  be  known  as  the  Graesser-Monsanto 
Chemical  Works,  Ltd.,  with  a  capital  of  £400,000  fully  paid.  The 
purpose  is  to  continue  not  only  the  manufacture  of  the  phenols  and 
cresols  formerly  made  by  the  Graesser  Company  but  likewise  to 
manufacture  in  the  plant  in  Wales  a  full  line  of  chemicals  as  manu- 
factured by  the  Monsanto  Chemical  Works  in  America. 
Lehn  &  Fink,  Inc.,  Announce  Further  Business  Advances. 
— Mr.  Wm.  J.  Gesell  and  Mr.  Robert  Plant,  officials  of  this  drug 
firm,  have  sailed  for  Europe  upon  a  business  trip.  They  will  in- 
vestigate market  conditions  abroad  and  secure  needed  drug  products 
for  the  American  market. 
Mr.  Edward  F.  Cunningham  is  now  connected  with  this  firm, 
paying  special  attention  to  the  Latin-American  field.  He  expects 
to  spend  the  summer  in  a  trip  to  Cuba,  Haiti,  San  Domingo,  Porto 
